Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
INO-5401 and INO-9012 delivered intramuscularly (IM) with electroporation (EP) in combination with cemiplimab (REGN2810) in newly diagnosed glioblastoma (GBM): Interim results. Reardon, D. A., Brem, S., Desai, A., Bagley, S., Kurz, S., De La Fuente, M., Nagpal, S., Welch, M., Hormigo, A., Carroll, N., Bartra, S. K., Campbell, P., Bhatt, K., Lowy, I., Boyer, J., Kraynyak, K., Morrow, M. P., McMullan, T., Weiner, D. B., Skolnik, J. AMER SOC CLINICAL ONCOLOGY. 2020
View details for Web of Science ID 000560368301209